Emotra AB announces that the Company has been granted financial support from the EU Horizon 2020 programme. The application, submitted in December 2015, is for a €50K grant to finance a phase 1 feasibility study to demonstrate the potential to broaden the EDOR indication range to include children and young people up to 20 years of age. The feasibility study will also include a review of the conditions to develop “EDOR Interconnect”, a global communication platform that will facilitate Emotra’s communication with clinical departments and serve them in different parts of the world.
160121 – Emotra – PM – EU grants Emotra financial support